S20-463 Immunoglobulin therapy for the treatment of insulin resistance and type 2 diabetes Stanford researchers in the Snyder lab have discovered and developed an innovative immunoglobulin modality for the treatment of insulin resistance and type 2 diabetes. Michael Snyder Andrew Lipchik Justin Annes Sooyeon Lee Anil Narasimha